Endocrinol Metab.
2023 Feb;38(1):174-174. 10.3803/EnM.2023.101.
Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea
- Affiliations
-
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Korea
- 2Research Institute of National Health Insurance Service Ilsan Hospital, Goyang, Korea
- 3Division of Endocrinology and Metabolism, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea
- KMID: 2539830
- DOI: http://doi.org/10.3803/EnM.2023.101
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea
- Chemoprevention of Gastric Cancer: Metformin
- The Metformin Use and Gastric Cancer Risk
- The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
- Metformin and Cancer in Type 2 Diabetes
